What a brutal six months it’s been for Surgery Partners. The stock has dropped 29.9% and now trades at $21.10, rattling many ...

Barclays analyst Andrew Mok CFA maintained a Hold rating on Surgery Partners (SGRY – Research Report) today and set a price target of $25.00.

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports.

RBC Capital analyst Frank Morgan maintained a Buy rating on Surgery Partners (NASDAQ:SGRY) Inc on Thursday, setting a price target ...

Explore Surgery Partners stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SGRY. Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other ...

Citigroup Maintains Buy on Surgery Partners, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.

While tariffs are cutting into defense stock returns, hope springs eternal with a big U.S. budget package on the way.

Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings ... we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available ...